Shahrokhzadeh Negin, Khorramnia Saeed, Jafari Amin, Ahmadinia Hassan
Rafsanjan University of Medical Scinces, Rafsanjan, Iran.
Department of Anesthesiology, School of Medicine, Ali Ibn Abitaleb Educational and Tretment Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Anesth Pain Med. 2023 Feb 17;13(1):e130904. doi: 10.5812/aapm-130904. eCollection 2023 Feb.
Postoperative pain management is one of the major challenges of surgeons and anesthesiologists.
This study aimed to determine the efficacy of topical ketorolac in post-hemorrhoidectomy pain management.
This clinical trial was conducted on 84 candidates for hemorrhoidectomy (grade-II hemorrhoids) who visited Ali ibn Abi-Talib hospital of Rafsanjan, Kerman, Iran (2020 - 2021). The participants were selected through convenience sampling and randomly assigned to three groups of 28. The subjects were treated in topical (4 mL 0.5% Marcaine + 1 mL ketorolac at the surgical site), intramuscular (4 mL 0.5% Marcaine at the surgical site + 1 mL ketorolac intramuscularly), and control (4 mL 0.5% Marcaine at the surgical site) groups. Pain intensity was measured using the Numerical Pain Rating Scale 1, 6, 12, and 24 hours after surgery. The obtained data were analyzed using two-way repeated measures analysis of variance.
Female and male patients constituted 46.4% and 53.6% of the participants, respectively. The mean pain intensity was significantly lower in the topical group than in intramuscular and control treatments in all four stages of pain assessment (P < 0.001). Some participants were treated with pethidine due to high pain intensity. However, the mean pain intensity gradually reduced over time in all three groups.
Study findings suggested that the topical administration of ketorolac and Marcaine was more effective than Marcaine used alone for relieving pain in patients undergoing hemorrhoidectomy.
术后疼痛管理是外科医生和麻醉医生面临的主要挑战之一。
本研究旨在确定外用酮咯酸在痔切除术后疼痛管理中的疗效。
本临床试验对84例痔切除术(II级痔疮)候选患者进行,这些患者就诊于伊朗克尔曼省拉夫桑詹市的阿里·伊本·阿比·塔利卜医院(2020 - 2021年)。参与者通过便利抽样选取,并随机分为三组,每组28人。受试者分别接受局部用药(手术部位使用4 mL 0.5%布比卡因 + 1 mL酮咯酸)、肌肉注射(手术部位使用4 mL 0.5%布比卡因 + 1 mL酮咯酸肌肉注射)和对照组(手术部位使用4 mL 0.5%布比卡因)治疗。术后1、6、12和24小时使用数字疼痛评分量表测量疼痛强度。所得数据采用双向重复测量方差分析进行分析。
女性和男性患者分别占参与者的46.4%和53.6%。在疼痛评估的所有四个阶段,局部用药组的平均疼痛强度均显著低于肌肉注射组和对照组(P < 0.001)。一些参与者因疼痛强度高而接受了哌替啶治疗。然而,三组的平均疼痛强度均随时间逐渐降低。
研究结果表明,对于接受痔切除术的患者,外用酮咯酸和布比卡因比单独使用布比卡因更有效地缓解疼痛。